Why is retatrutide more expensive than semaglutide
Tang H, Donahoo WT, DeKosky ST, Lee YA, Kotecha P, Svensson M, Bian J, Guo J (2025) GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias
Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials
All three were funded by Eriomins manufacturer and conducted by the same group of researchers
Navigating Supply Shortages We cannot talk about microdosing without talking about the shortages
The 12 week phase 1b clinical trial for patients with type 2 diabetes from December 18, 2018 to December 28, 2020 showed that the three high-dose groups of Retatrutide were significantly better than the placebo control group in reducing blood sugar and glycosylated hemoglobin (HbA1c), and showed a dose related weight loss effect